drugset / Trial / NCT00469716

Hypertonic Saline-hetastarch in Cardiac Surgery

NCT00469716

Phase 4 Completed 50 enrolled Haukeland University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

Cardiopulmonary bypass(CPB) is associated with increased fluid extravasation and edema formation. A continuous infusion of a mixture of hypertonic saline/hydroxyethyl starch (HSH)during CPB reduced fluid extravasation and total fluid gain during bypass in an animal model. We hypothesize that a continuous infusion of HSH will reduce fluid load and increase hemodynamic and respiratory functions in patients undergoing coronary artery bypass with CPB.

Timeline

Start
2007-04
Primary completion
2008-05
Completion
2008-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown
Subject hetastarch Other / unclassified

Indications